Len Yaffee, Kessef Capital, join ‘Fast Money’ to talk Amgen’s obesity drug, Eli Lilly’s current stock action, and much more.
05:37
3 hours ago
Trending
- 'Fast Money' traders talk if we are all clear for a year-end rally
- How I Got A Free $25 Gift Card For Scanning Receipts
- Two National Guardsman in critical condition following shooting near White House
- AI data center ‘frenzy’ is pushing up your electric bill — here’s why
- South Korea keeps rates steady as FX risks limit easing scope
- Hard for Eli Lilly to move significantly higher from here in the short-term: Kessef Capital’s Yaffee
- China industrial profits drop 5.5% in October, worst level in five months
- Social media users report Netflix outage as ‘Stranger Things’ returns
Hard for Eli Lilly to move significantly higher from here in the short-term: Kessef Capital’s Yaffee
